Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Must Reads by Date

Must reads for theWeek ending June 25, 2017

The Challenges of MPN Diagnosis and Risk Assessment, N Engl J Med; 2017 Jun 1; Spivak

How Post PPV and ET Differ from Primary Myelofibrosis , Leuk Res; 2017 Jun 2; Masarova, Bose, Daver et al

Timing of Antibiotic Administration for Neutropenic Fever, J Oncol Pharm Pract; 2017 Jun; Butts, et al

Tyrosine Kinase Inhibitors in Patients with AML, Stem Cell Investig; 2017 Jun 2; Chen, Pan, et al

Online Yoga Intervention in MPN Patients Evaluated, Haematologica; ePub 2017 Jun 8; Huberty, et al

More must reads

Must reads for theWeek ending June 25, 2017

The Challenges of MPN Diagnosis and Risk Assessment, N Engl J Med; 2017 Jun 1; Spivak

How Post PPV and ET Differ from Primary Myelofibrosis , Leuk Res; 2017 Jun 2; Masarova, Bose, Daver et al

Timing of Antibiotic Administration for Neutropenic Fever, J Oncol Pharm Pract; 2017 Jun; Butts, et al

Tyrosine Kinase Inhibitors in Patients with AML, Stem Cell Investig; 2017 Jun 2; Chen, Pan, et al

Online Yoga Intervention in MPN Patients Evaluated, Haematologica; ePub 2017 Jun 8; Huberty, et al

More must reads

Must reads for theWeek ending June 11, 2017

Monocytosis Prevalence in PV Evaluated, Am J Hematol; ePub 2017 May 26; Barraco, et al

These MPNs Are More Likely to Progress to Leukemia, Future Oncol; ePub 2017 Jun 7; Shrestha, et al

TIPS for Resolving Portal Hypertension in MPN Patients, Am J Hematol; ePub 2017 May 24; Reilly, et al

Outcomes After UCBT in MDS Patients Evaluated, Biol Blood Marrow Transplant; 2017 Jun; Gerds, et al

IGHV Mutational Status Testing in Patients with CLL, Am J Hematol; ePub 2017 Jun 7; Crombie, et al

More must reads

Must reads for theWeek ending June 11, 2017

Monocytosis Prevalence in PV Evaluated, Am J Hematol; ePub 2017 May 26; Barraco, et al

These MPNs Are More Likely to Progress to Leukemia, Future Oncol; ePub 2017 Jun 7; Shrestha, et al

TIPS for Resolving Portal Hypertension in MPN Patients, Am J Hematol; ePub 2017 May 24; Reilly, et al

Outcomes After UCBT in MDS Patients Evaluated, Biol Blood Marrow Transplant; 2017 Jun; Gerds, et al

IGHV Mutational Status Testing in Patients with CLL, Am J Hematol; ePub 2017 Jun 7; Crombie, et al

More must reads

Must reads for theWeek ending May 28, 2017

Practical Measures of Ruxolitinib’s Clinical Benefit, Clin Lymphoma Myeloma Leuk; ePub 2017 May 12; Miller, et al

Fewer Thromboembolic Events with Ruxolitinib?, Br J Haematol; ePub 2017 May 17; Harrison, et al

JAK Inhibitors’ Role in Symptom Relief Reviewed, Biol Blood Marrow Transplant; ePub 2017 May 9; Jain, et al

Ruxolitinib’s for MF and Potential in ET Reviewed, Blood; ePub 2017 May 12; Bose, Verstovsek

Cost of Antithrombin Therapy in Hematologic Malignancies, Leuk Lymphoma; ePub 2017 May 9; Barreto, et al

More must reads

Pages